MoneyTreeTM: Dollar drought

August 2012
  • Print-friendly version

At a glance

MoneyTree: biotechnology and medical device venture capital investments

Venture capitalists invested $1.4 billion in 174 life sciences deals, continuing a decline spanning four consecutive quarters. The Biotechnology and Medical Devices industries saw investments fall 39% in dollars and 22% in number of deals during the second quarter of 2012 from the same quarter of last year, according to the MoneyTreeTM Report from PricewaterhouseCoopers (PwC) LLP and the National Venture Capital Association (NVCA) based on data provided by Thomson Reuters.

MoneyTree: Dollar drought